EFFECT OF RECOMBINANT FACTOR VIIA ASSESSED BY THROMBOCYTE IMMUNO-PHENOTYPING ON THE EXPRESSION OF PLATELET’S FIBRINOGEN RECEPTORS IN BLEEDING DISORDERS – preliminary results

E. Moisescu ^*, Delia Mut Popescu ^*, H Bumbea ^*, Luminița Ardelean ^*, Viorica-lleana Bumbea ^*,
Mihaela Vartic ^*, Ioana Simion ^*, A Mureșan ^*, Mihaela Luca ^*, B. Opriță ^*, A. Iancu ^*
* RESEARCH TEAM:
Moisescu Emilian M.D. – Bucharest Emergency Hospital – coordinator, Intensive Care Department
Popescu Mut Delia Ph D M.D. – “Carol Davila” University of Medicine, Department of Hematology
Bumbea Horia M.D. – “Carol Davila” University of Medicine Department of Hematology
Ardelean Luminița M.D. – Bucharest Emergency Hospital, Department of Hemodialysis
Bumbea Viorica-lleana M.D. – Bucharest Emergency Hospital, Department of Hemodialysis
Varlic Mihaela M.D. – Bucharest Emergency Hospital, Intensive Care Department
Simion Ioana M.D. – “N. Gh. Lupu” Institute of Medicine, Intensive Care Department
Muresan Andrei M.D. – Bucharest Emergency Hospital, Intensive Care Department
Luca Mihaela – principal biochemist – Bucharest Emergency Hospital
Oprita Bogdan M.D. – Bucharest Emergency Hospital, Emergency Medicine
Adrian Iancu M.D. – Novo Nordisk AS Medical Representative Office Romania